Biomarin Pharmaceutical (BMRN) Capital Expenditures (2009 - 2026)
Biomarin Pharmaceutical's Capital Expenditures came in at $28.82 million for Q2 2026, up 68.5% from $17.1 million a year earlier and up 37.7% from the prior quarter.
Biomarin Pharmaceutical (BMRN) Capital Expenditures (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biomarin Pharmaceutical reported Capital Expenditures of $118.91 million, up 65.5% year-over-year; for FY2025, it came in at $103.04 million, up 20.6% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $85.42 million in FY2024 (-11.7%), $96.69 million in FY2023 (-20.1%), $120.96 million in FY2022 (+26.6%) and $95.58 million in FY2021 (-16.4%).
- The five-year range for quarterly Capital Expenditures is $16.77 million (Q1 2025) to $40.72 million (Q4 2025).
- Year-over-year, Capital Expenditures has increased for four consecutive quarters, with growth averaging 19.1% over the last eight quarters.
- The fastest year-over-year change in Capital Expenditures over five years came in Q4 2025 (growth of 108.5%), and the weakest in Q1 2025 (a decline of 35.8%).
- Business Quant data shows BMRN's Capital Expenditures at $20.92 million (Q1 2026), $40.72 million (Q4 2025) and $28.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Biomarin Pharmaceutical | 11.59 Bn | 5.45 Bn | 786.91 Mn | 28.82 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.82 Mn |
| Mar 31, 2026 | 20.92 Mn |
| Dec 31, 2025 | 40.72 Mn |
| Sep 30, 2025 | 28.45 Mn |
| Jun 30, 2025 | 17.10 Mn |
| Mar 31, 2025 | 16.77 Mn |
| Dec 31, 2024 | 19.53 Mn |
| Sep 30, 2024 | 18.46 Mn |
| Jun 30, 2024 | 21.33 Mn |
| Mar 31, 2024 | 26.10 Mn |
| Dec 31, 2023 | 28.92 Mn |
| Sep 30, 2023 | 21.74 Mn |
| Jun 30, 2023 | 21.58 Mn |
| Mar 31, 2023 | 24.46 Mn |
| Dec 31, 2022 | 35.69 Mn |
| Sep 30, 2022 | 29.30 Mn |
| Jun 30, 2022 | 27.15 Mn |
| Mar 31, 2022 | 28.82 Mn |
| Dec 31, 2021 | 28.74 Mn |
| Sep 30, 2021 | 18.73 Mn |
Biomarin Pharmaceutical Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BMRN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();